223 related articles for article (PubMed ID: 23704824)
1. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
Sun W; Dong WW; Mao LL; Li WM; Cui JT; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(19):2913-20. PubMed ID: 23704824
[TBL] [Abstract][Full Text] [Related]
2. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
3. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract][Full Text] [Related]
5. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
7. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
8. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
[TBL] [Abstract][Full Text] [Related]
12. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
[TBL] [Abstract][Full Text] [Related]
13. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
14. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma.
Zhang W; Xie HY; Ding SM; Xing CY; Chen A; Lai MC; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):289-96. PubMed ID: 27298105
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
16. Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.
Ni QF; Tian Y; Kong LL; Lu YT; Ding WZ; Kong LB
Oncol Rep; 2014 Mar; 31(3):1364-72. PubMed ID: 24399246
[TBL] [Abstract][Full Text] [Related]
17. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
18. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
Chang W; Yu Z; Tian M; Lin X
Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
20. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
Rong M; Chen G; Dang Y
BMC Cancer; 2013 Jan; 13():21. PubMed ID: 23320393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]